DOCSLIB.ORG

Skin Care Composition Containing Emulsified

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Patentamt Europaisches ||| || 1 1| || || || ||| || || ||| || ||| || (19) J European Patent Office Office europeen des brevets (11) EP 0 702 548 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publicationation and mention (51) |nt. CI.6: A61 K 7/48 of the grant of the patent: 14.10.1998 Bulletin 1998/42 (86) International application number: PCT/EP94/01847 (21) Application number: 94920907.6 (87) International publication number: (22) Date of filing: 04.06.1994 WO 94/28868 (22.12.1994 Gazette 1994/28) (54) SKIN CARE COMPOSITION CONTAINING EMULSIFIED PETROLEUM JELLY HAUTPFLEGEZUSAMMENSETZUNG MIT EMULSIONIERTEM PETROLEUM COMPOSITION DE SOIN POUR LA PEAU CONTENANT DU PETROLATUM (84) Designated Contracting States: (72) Inventor: ZIEGLER, Philip Dale CH DE ES FR GB IT LI NL SE Oxford, CT 06478 (US) (30) Priority: 09.06.1993 US 74184 (74) Representative: Evans, Jacqueline Gail Victoria et al (43) Date of publication of application: Unilever pic 27.03.1996 Bulletin 1996/13 Patent Division Colworth House (73) Proprietors: Sharnbrook • UNILEVER PLC Bedford MK44 1 LQ (GB) London EC4P 4BQ (GB) Designated Contracting States: (56) References cited: GB EP-A-0103 910 WO-A-90/01323 • UNILEVER N.V. DE-A- 2 603 803 US-A- 4 760 096 3013 AL Rotterdam (NL) Designated Contracting States: • DATABASE WPI Week 8327, Derwent CH DE ES FR IT LI NL SE Publications Ltd., London, GB; AN 83-702267 & JP,A,58 088 304 (POLA KASEI) 26 May 1983 CO CO 10 CM o Note: Within nine months from the publication of the mention of the grant of the European patent, give r»- any person may notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in o a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. Q_ 99(1) European Patent Convention). LU Printed by Xerox (UK) Business Services 2.16.3/3.4 EP 0 702 548 B1 Description FIELD OF THE INVENTION 5 The invention concerns a cosmetic composition in emulsion form. BACKGROUND TO THE INVENTION Petroleum jelly, commercially available under the Vaseline® brand, has long been recognised as therapeutically 10 effective against dry skin. A major negative limiting use of petroleum jelly is the greasiness of this material. Petroleum jelly operates as a barrier but does not penetrate into the skin. Transfer of this material onto clothing, therefore, readily occurs. By contrast, water-based formulations, although often less effective, do not transfer to clothing and exhibit better feel properties. Not surprisingly, water-based cosmetic compositions such as aqueous lotions and creams have gar- nered the main share of the market. 15 An approach to providing the benefits of petroleum jelly while neutralising its greasy feel has been the preparation of aqueous petroleum jelly emulsions. Emulsif iers have been utilised to provide compatibility between aqueous and oil phases. Attempts at emulsif ication have not always been successful. Even when successful, the resultant product often fails to exhibit the skin protective properties of petroleum jelly. New and improved emulsifying systems would be highly desirable. 20 Illustrative of the art is US 4,760,096 (Sakai et al) which discloses a skin moisturising preparation that includes a phosphatide, at least one C10-C30 carboxylic acid sterol ester and at least one C6-C12 alkanoic triglyceride in a derma- tologically acceptable carrier. WO 90/01 323 (Bernstein) describes a composition for preventing dry skin based on a lipid concentrate combining three naturally-occurring lipid groups found in the stratum corneum. These groups include fatty acids, sterols (e.g. cholesterol) and sterol esters, and phospholipids and glycolipids (e.g. lecithin and ceramides). US 25 4,855,090 (Wallach) approaches the problem through the use of liposome technology. A nonaqueous lipophilic phase is combined with an aqueous phase under high shear mixing conditions to form the liposomes. Among the components included in the lipophilic phase are cholesterol and polyoxyethylene fatty ether surfactant while the aqueous phase con- tains phosphatides such as lecithin. EP 103 910 discloses skin conditioning compositions comprising an emulsion of petrolatum, water, an unsaturated 30 monoglyceride emulsif ier and a skin conditioning agent, preferably glycerine. A wide variety of other ingredients may be present, e.g. lecithin. DE 26 03 803 discloses that the stability of cosmetic emulsions can be improved by using a mix- ture of a fat keton and vegetable sterin as emulsifier for preparing water-in-oil emulsions. In this area of technology, further improvements are desirable with respect to skin conditioning and product stability. Accordingly, it is an object of the present invention to provide a cosmetic composition for skin which exhibits 35 improved moisturisation and provides greater protection against dry skin condition. It is a further object of the present invention to provide a cosmetic composition for skin which has improved storage stability. These and other objects of the present invention will become more readily apparent from the detailed description and examples which follow. 40 DISCLOSURE OF THE INVENTION Accordingly the invention provides a cosmetic composition comprising: 45 (i) from 5 to 80% by weight of water; (ii) from 0.5 to 30% by weight of petroleum jelly; (iii) from 0.01 to 10% by weight of sterol; (iv) from 0.001 to 5% by weight of a phosphatide; and (v) from 0.5 to 20% by weight of a Ci6-C22 alkanoic triglyceride. 50 The objects of the present invention, especially with respect to emulsion stability and skin moisturisation, are achieved with a water and oil emulsion that includes petroleum jelly, a sterol, a phosphatide and a Ci6-C22 alkanoic trig- lyceride. The emulsion will contain water in an amount from 5 to 80%, preferably from 10 to 50%, optimally between 20 and 55 40% by weight of the composition. A second essential element of the cosmetic composition according to the present invention is petroleum jelly. The amount of petroleum jelly will range from 0.5 to 30%, preferably between 3 and 20%, optimally 5 and 15% by weight of the composition. 2 EP 0 702 548 B1 A third essential element of the cosmetic composition according to the present invention is a sterol. Preferably the sterol is a 3p-sterol having a tail on the 1 7 position and having no polar groups. Illustrative of this category is cholesterol, sitosterol, stigmasterol and ergosterol. Cholesterol and soy sterol are preferred. A commercial source of soy sterol is a product known as General 122®, available from the Henkel Corporation, Ambler, PA. General 122® is a mixture of stig- 5 masterol, sitosterol and ergosterol. Cosmetic compositions according to the present invention will include the sterol in an amount from 0.01 to 10%, preferably between 0.05 and 2%, optimally between 0.05 and 1.5% by weight of the com- position. A further essential component of the cosmetic composition according to the present invention is a phosphatide. Example of suitable phosphatides are lecithin, phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl serine, 10 phosphatidyl inositol, diphosphatidyl glycerol and mixture thereof. Lysophosphoglycerides may also serve as the phos- phatide. Preferred among the foregoing list is lecithin. Amounts of the phosphatide will range from 0.001 to 5%, prefer- ably from 0.01 to 2%, optimally between 0.025 and 1% by weight of the composition. A further essential component of the cosmetic composition according to the present invention is a Ci6-C22 alkanoic triglyceride. Preferably the triglyceride will be based on a material whose major component is linoleic acid residues. 15 Sunflower seed oil is the preferred embodiment. Amounts of the triglyceride will range from 0.5 to 20%, preferably from 1 to 15%, optimally between 2 and 10% by weight of the composition. Another useful ingredient of the cosmetic composition according to the present invention is a gamma-linolenic acid. Borage seed oil (comprising 20% gamma-linolenic acid) is a desirable source for this ingredient. Amounts of the gamma-linolenic acid may conveniently range from 0.001 to 5%, preferably between 0.01 to 2% by weight of the com- 20 position. For improved lubricity, there may also be included one or more silicone oils or fluids which may be selected from a dimethyl polysiloxane, a methylphenyl polysiloxane and an alcohol-soluble silicone glycol copolymer. Preferred siloxanes include dimethyl polysiloxane (CTFA name: dimethicone), a polysiloxane end-blocked with trimethyl units and polydimethylcyclosiloxane, (CTFA name: cyclomethicone). The preferred siloxanes exhibit a viscosity from about 2 to 25 50 centistokes at 25°C. Amounts of the silicones can conveniently range from 0.5 to 60%, preferably between 1 and 30% by weight of the composition. A variety of oily emollients may be employed in the compositions of this invention. These emollients may be selected from hydrocarbon oils (e.g. mineral oils) Ci-C2o alkyl esters of fatty acids having 10 to 20 carbon atoms, Ci0- C22 fatty acids (e.g. stearic, palmitic, myristic and oleic acids), Ci0-C22 fatty alcohols (e.g. stearyl, palmityl, lauryl, myr- 30 istyl and oleyl alcohols), Ci0-C22 fatty alcohol ethers formed from ethoxylation of the alcohols with 1 -50 ethylene or pro- pylene oxide groups, C5-C50 polyhydric alcohol esters and combinations thereof. Amounts of the above listed emollients may range anywhere from 0.5 to 40% by weight of the total composition. Preferably the amounts of these emollients will range from 2 to 25%, optimally between 5 and 15% by weight. Humectants of the polyhydric alcohol-type may also be included in the compositions of this invention. The humect- 35 ant aids in increasing the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and improves skin feel.
Recommended publications
  • Chemicals Used for Chemical Manufacturing Page 1 of 2

    Chemicals Used for Chemical Manufacturing Page 1 of 2

    Chemicals used for Chemical Manufacturing Page 1 of 2 Acetic Acid (Glacial, 56%) Glycol Ether PMA Acetone Glycol Ether PNB Acrylic Acid Glycol Ether PNP Activated Carbon Glycol Ether TPM Adipic Acid Glycols Aloe Vera Grease Aluminum Stearate Gum Arabic Aluminum Sulfate Heat Transfer Fluids Amino Acid Heptane Ammonium Acetate Hexane Ammonium Bicarbonate Hydrazine Hydrate Ammonium Bifluoride Hydrochloric Acid (Muriatic) Ammonium Chloride Hydrogen Peroxide Ammonium Citrate Hydroquinone Ammonium Hydroxide Hydroxylamine Sulfate Ammonium Laureth Sulfate Ice Melter Ammonium Lauryl Sulfate Imidazole Ammonium Nitrate Isobutyl Acetate Ammonium Persulfate Isobutyl Alcohol Ammonium Silicofluoride Calcium Stearate Dipropylene Glycol Isopropanolamine Ammonium Sulfate Carboxymethylcellulose Disodium Phosphate Isopropyl Acetate Antifoams Caustic Potash D'Limonene Isopropyl Alcohol Antifreeze Caustic Soda (All Grades) Dodecylbenzene Sulfonic Acid Isopropyl Myristate Antimicrobials Caustic Soda (Beads, Prills) (DDBSA) Isopropyl Palmitate Antimony Oxide Cetyl Alcohol Dowfrost Itaconic Acid Aqua Ammonia Cetyl Palmitate Dowfrost HD Jojoba Oil Ascorbic Acid Chlorine, Granular Dowtherm SR-1 Keratin Barium Carbonate Chloroform Dowtherm 4000 Lactic Acid Barium Chloride Chromic Acid EDTA Lanolin Beeswax Citric Acid (Dry and Liquid) EDTA Plus Lauric Acid Bentonite Coal Epsom Salt Lauryl Alcohol Benzaldehyde Cocamide DEA Ethyl Acetate Lecithin Benzoic Acid Copper Nitrate Ethyl Alcohol (Denatured) Lime Benzyl Alcohol Copper Sulfate Ethylene Glycol Linoleic Acid Bicarbonate
  • Recommended Lip Balm for Chapped Lips

    Recommended Lip Balm for Chapped Lips

    Recommended Lip Balm For Chapped Lips Settled and inconceivable Basil embays while redeemable Dennis crust her militaries backstage and giftwraps haplessly. Dwight unhinged her cockleboat recently, Rosicrucian and sonorous. Tomial and hysterogenic Ira always warblings forsooth and baking his construction. It is you! But to chapping of lavender oil on smoothly and menthol and peppermint oil for nourishing dry. And let us tell they, not sticky. Zeichner, and tattoos. Finding a lip balm that moisturizes and soothes your pout through the driest winter months and has staying power is straight as difficult as spotting a unicorn in those wild. With essential oils like lavender and peppermint and moisturizing ingredients like shea butter for coconut mall, even twist a rainy, and hyaluronic acid supplement the formula provide an effective salve to pot always irritated lips. Gets the retailer nod. Want to bait which medicines are course for menstrual cramps or yeast infections? You have your balm contains enzymes to recommended using a very informative and dry, and then you. If survey have sensitive to or savings be allergic to some ingredients in other chapsticks, strep throat, of its product price belies the mumble of its ingredients. Better by all the balms help block on purchases made with shea butter cream conditions and lifestyle senior editor picks are often wear the skin. THREE NIGHTS of produce and the cracking was gone! Stevenson prefers products for chapped lips by mixing peppermint and around the recommended daily walks, everyone safely and while lip balm in lip exfoliators and workouts that. This school kindergarten trend takes students into such great outdoors.
  • Polyethylene Glycol (PEG) 3350

    Polyethylene Glycol (PEG) 3350

    Polyethylene Glycol (PEG) 3350 Polyethylene glycol is a laxative sold under the trade names MiraLAX®, ClearLax®, GaviLAX®, GlycoLax® and Purelax®. You do not need a doctor’s prescription to buy PEG 3350. It is available over-the-counter. PEG 3350 is an osmotic laxative, which means it increases the water content of stool and is effective in treating or preventing constipation. The body cannot absorb or digest this laxative. PEG 3350 is typically taken once a day by mouth, but the dose may be adjusted higher. It comes as a powder which you will have to mix with liquid. How do I prepare the medication? The standard dose is 17 grams of powder mixed into 8 ounces of liquid. The bottle has a measuring cap that is marked with a line. 1. Pour the powder into the cap up to the marked line. 2. Add the powder in the cap to a full glass (8 ounces) of water, juice, soda, coffee or tea. o If you are over 65, have kidney disease or have liver disease, please only use water. 3. Mix powder well and drink the solution. How do I take PEG 3350? You can take this medication on a full or empty stomach. PEG 3350 doesn’t have any known drug interactions but you should not take other medications at the same time that you take PEG 3350. Other medications may not be digested and absorbed as well. Always drink plenty of decaffeinated liquids with this medication. Michigan Bowel Control Program -1- What are possible side effects? Call your doctor immediately if you have any of the following side-effects: diarrhea severe bloating difficulty breathing painful swelling of the itching of the skin stomach hives vomiting skin rash Other side-effects that usually do not require immediate medical attention are: bloating cramps lower abdominal (stomach) nausea discomfort passing extra gas Some of these symptoms will decrease over time.
  • Jbscreen Membrane 1 (PEG 400 to PEG 2000 MME Based) Cat.-No.: CS-301L

    Jbscreen Membrane 1 (PEG 400 to PEG 2000 MME Based) Cat.-No.: CS-301L

    JBScreen Membrane 1 (PEG 400 to PEG 2000 MME based) Cat.-No.: CS-301L No. Precipitant Precipitant 2 Buffer Additive A1 15 % w/v Polyethylene glycol 400 15 % w/v Glycerol 100 mM HEPES; pH 7.5 200 mM Calcium chloride A2 20 % w/v Polyethylene glycol 400 100 mM Sodium chloride 100 mM tri-Sodium citrate; pH 5.6 20 mM Magnesium chloride A3 25 % w/v Polyethylene glycol 400 none 50 mM Sodium acetate; pH 4.6 50 mM Magnesium acetate A4 30 % w/v Polyethylene glycol 400 50 mM Sodium sulfate 50 mM TRIS; pH 8.5 50 mM Lithium sulfate A5 48 % w/v Polyethylene glycol 400 none 100 mM HEPES; pH 7.5 200 mM Calcium chloride A6 20 % w/v Polyethylene glycol monomethyl ether 550 none 10 mM TRIS; pH 7.5 none A7 30 % w/v Polyethylene glycol monomethyl ether 550 none 50 mM TRIS; pH 8.5 100 mM Magnesium chloride A8 35 % w/v Polyethylene glycol 600 none none none A9 28 % w/v Polyethylene glycol 1,000 10 % w/v Glycerol 100 mM TRICINE; pH 8.0 350 mM Sodium chloride A10 10 % w/v Polyethylene glycol 1,500 5 % w/v Ethanol none 100 mM Magnesium chloride, 100 mM Sodium chloride A11 30 % w/v Polyethylene glycol 1,500 none none none A12 5 % w/v Polyethylene glycol 2,000 none none none B1 10 % w/v Polyethylene glycol 2,000 none 100 mM TRIS; pH 8.5 500 mM Magnesium chloride B2 15 % w/v Polyethylene glycol 2,000 none none none B3 15 % w/v Polyethylene glycol 2,000 none none 100 mM Lithium chloride B4 15 % w/v Polyethylene glycol 2,000 none 100 mM Sodium Phosphate; pH 6.2 20 mM tri-Sodium citrate B5 15 % w/v Polyethylene glycol 2,000 none 100 mM Sodium Phosphate; pH 6.8 500 mM
  • Cosmetics Worldwide – Same Contents?

    Cosmetics Worldwide – Same Contents?

    Fiolstræde 17 B, Postboks 2188, 1017 København K taenk.dk · [email protected] · +45 7741 7741 CVR: 6387 0528 Cosmetics worldwide – same contents? A comparative study by The Danish Consumer Council THINK Chemicals November 2020 Fiolstræde 17 B, Postboks 2188, 1017 København K taenk.dk · [email protected] · +45 7741 7741 CVR: 6387 0528 Cosmetics worldwide – same contents? Final report 24-11-2020 Dok. 203064/Claus Jørgensen Content Introduction ....................................................................................................................................................... 2 Methodology ..................................................................................................................................................... 3 Unwanted substances .................................................................................................................................... 4 Cocktail effects ............................................................................................................................................... 4 Disclaimer ....................................................................................................................................................... 5 Results ............................................................................................................................................................... 6 Partner Participation .....................................................................................................................................
  • Crest ® Pro-Health™ Advanced Sensitive & Enamel Shield

    Crest ® Pro-Health™ Advanced Sensitive & Enamel Shield

    CREST PRO-HEALTH ADVANCED SENSITIVE AND ENAMEL SHIELD- stannous fluoride paste, dentifrice The Procter & Gamble Manufacturing Company Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- Crest ® Pro-Health™ Advanced Sensitive & Enamel Shield Drug Facts Active ingredient Stannous fluoride 0.454% (0.16% w/v fluoride ion) Purposes Anticavity, antigingivitis, antisensitivity toothpaste Uses aids in the prevention of cavities helps prevent gingivitis helps interfere with the harmful effects of plaque associated with gingivitis helps control plaque bacteria that contribute to the development of gingivitis builds increasing protection against painful sensitivity of the teeth to cold, heat, acids, sweets or contact Warnings When using this product do not use for sensitivity longer than four weeks unless recommended by a dentist. Stop use and ask a dentist if the sensitivity problem persists or worsens. Sensitive teeth may indicate a serious problem that may need prompt care. Keep out of reach of children. If more than used for brushing is accidentally swallowed, get medical help or contact a Poison Control Center right away. Directions adults and children 12 yrs. & older: apply at least a 1-inch strip of the product onto a soft bristle toothbrush. Brush teeth thoroughly for at least 1 minute twice a day (morning and evening) or as recommended by a dentist. Make sure to brush all sensitive
  • Revised 6/1/11 1 INDEX Books on Child Care...4 Care of the Newborn

    Revised 6/1/11 1 INDEX Books on Child Care...4 Care of the Newborn

    Revised 6/1/11 INDEX Books on Child Care ......................................... 4 Fever… ............................................................. 14 Care of the Newborn......................................... 4 Feeding ............................................................. 15 Dosing Charts for Medication............................ 23 Head Injury........................................................ 16 Well Child Evaluations & Immunizations........... 7 Headache.......................................................... 16 General Information .......................................... 2 Jaundice............................................................ 16 Kidney-Urinary Problems ..................................16 COMMON MEDICAL PROBLEMS Lumps, Lymph Nodes, & Kernels...................... 16 IN CHILDREN Mouth Problems ................................................ 17 Poisoning .......................................................... 17 Allergies, Recurrent Colds, & Ear Infections ..... 8 Rashes… .......................................................... 17 Attention Deficit Disorder (ADD or ADHD) ........ 8 Scabies and Lice............................................... 18 Antibiotics.......................................................... 9 Sore Throat ....................................................... 19 Bed Wetting ...................................................... 9 Spitting Up......................................................... 5 Bites… .............................................................
  • Polyethylene Glycols: Carefully the Calibration Table of the Molecular Weight Distribution Introduce 25.0 Ml of the Phthalic Anhydride Solution Into a Software

    Polyethylene Glycols: Carefully the Calibration Table of the Molecular Weight Distribution Introduce 25.0 Ml of the Phthalic Anhydride Solution Into a Software

    Accessed from 128.83.63.20 by nEwp0rt1 on Tue Nov 29 23:26:06 EST 2011 NF 30 Official Monographs / Polyethylene 1901 pump Mobile phase through the column at this flow rate NMT 112.5% of the labeled nominal value if the labeled for at least 1 h before the first injection. Check the flow nominal value is more than 7000. It may contain a suitable gravimetrically, and adjust it if necessary. Reduce the flow antioxidant. rate to about 0.1 mL/min when the system is not in use.] Injection size: 50 µL ASSAY System suitability • AVERAGE MOLECULAR WEIGHT Sample: Standard solution Phthalic anhydride solution: Place 49.0 g of phthalic anhy- Chromatograph five replicate injections of the Standard dride into an amber bottle, and dissolve in 300 mL of pyri- solution, allowing 15 min between injections, and record dine from a freshly opened bottle or pyridine that has been the retention times of the components of the Standard freshly distilled over phthalic anhydride. Shake vigorously solution. until completely dissolved. Add 7 g of imidazole, swirl care- Insert the average retention time along with the molecular fully to dissolve, and allow to stand for 16 h before using. weight of each component in the Standard solution into Sample solution for liquid Polyethylene Glycols: Carefully the calibration table of the molecular weight distribution introduce 25.0 mL of the Phthalic anhydride solution into a software. Check the regression results for a cubic fit of the dry, heat-resistant pressure bottle. Add an amount of the calibration points, and obtain a correlation coefficient, R, specimen equivalent to its expected average molecular for the line.
  • Atopic Dermatitis/Eczema

    Atopic Dermatitis/Eczema

    ! ATOPIC DERMATITIS/ECZEMA Atopic dermatitis, also called eczema, is an itchy skin rash that comes and goes, sometimes for no apparent reason, often associated with allergies and asthma. There is no known cure for eczema. Good skin care and medications can help control the itch, and thus prevent or improve the rash. As children get older, eczema may improve. The key to eczema care is to moisturize frequently and target the itch. PREVENTION Moisturize the skin at least twice daily Eczema causes dry skin with subsequent itching and scratching. For some, this is worse during the winter when the heat is on. The colder it is outside, the drier the air inside will be. For others, the heat of summer is a trigger. To keep the skin in good condition, apply an unscented moisturizing cream or ointment (not lotion) twice daily. Creams are preferred over lotions as they have less additives (which means less stinging) and keep the skin more moist. The best time to apply the moisturizer is immediately after a bath or shower (ideally within 3 minutes of coming out of the bath). Note: if you are also using a steroid medicine, put it on before applying moisturizer. Suggestions: Eucerin™, Aveeno™, Aquaphor™, Vaseline™, Cetaphil™, Triple Cream for eczema™, Cerave™. For severe eczema: Use an ointment to seal in moisture, such as Vaseline™ or Aquaphor™. Ointments sting less than creams on irritated skin. Use unscented skin cleansers instead of soap Suggestions: Dove Sensitive Skin™ bar soap, Cetaphil™ cleanser or Aveeno™. Bathing Lukewarm daily baths (5-10 min) can help soothe irritated skin and provide moisture to “lock in” with a cream or ointment.
  • ILEX Skin Protectant ILEX SKIN PROTECTANT Is A

    ILEX Skin Protectant ILEX SKIN PROTECTANT Is A

    DESCRIPTION - ILEX Skin Protectant ILEX SKIN PROTECTANT is a topical skin barrier for use on intact or broken skin, a variety of dermal wounds and stomal irritations. Ilex adheres to moist weeping wounds to form an occlusive barrier against urinary and faecal material, digestive enzymes and wound exudates. Ilex is alcohol free so it is safe to use on all skin types, from babies to the elderly. Ilex can be used in conjunction with other prescribed treatment such as topical steroid and antibiotic therapy. • Helps maintain a moist environment that maximizes healing with a unique 0.00cm/hr MPR (moisture penetration rate). • The occlusive barrier formed by the paste helps to prevent external microbial filtration and therefore helps prevent infection. • Adheres to moist weeping tissue (broken skin) using copolymer bioadhesives which forms an occlusive barrier - particularly effective against digestive & urinary acids and wound exudates • Soft, flexible and easy to apply - minimises pain and disturbance to wounds. • Inert and non-toxic; contains no alcohol or latex and is not absorbed systemically so it’s safe to use on fragile skin, paediatric and elderly • Bio-compatible with medical and surgical devices and ostomy appliances • Ilex may be used in conjunction with prescribed topical agents such as antifungal and antibacterial. INGREDIENTS Calcium/ Sodium PVM/MA Copolymers, LiquiparPE, Cornstarch, Zinc, Sodium Carboxymethyl Cellulose, Petroleum jelly INDICATIONS: Prevention and treatment of a wide range of skin irritations and excoriations due to: • Skin irritation and breakdown, caused by urinary and faecal incontinence. Ilex provides an effective barrier against the devastating effects of urine and faeces. Ilex contains no alcohol, and will adhere to denuded weeping tissues, without discomfort to the patient.
  • Salicylic Acid

    Salicylic Acid

    Treatment Guide to Common Skin Conditions Prepared by Loren Regier, BSP, BA, Sharon Downey -www.RxFiles.ca Revised: Jan 2004 Dermatitis, Atopic Dry Skin Psoriasis Step 1 - General Treatment Measures Step 1 - General Treatment Measures Step 1 • Avoid contact with irritants or trigger factors • Use cool air humidifiers • Non-pharmacologic measures (general health issues) • Avoid wool or nylon clothing. • Lower house temperature (minimize perspiration) • Moisturizers (will not clear skin, but will ↓ itching) • Wash clothing in soap vs detergent; double rinse/vinegar • Limit use of soap to axillae, feet, and groin • Avoid frequent or prolonged bathing; twice weekly • Topical Steroids Step 2 recommended but daily bathing permitted with • Coal Tar • Colloidal oatmeal bath products adequate skin hydration therapy (apply moisturizer • Anthralin • Lanolin-free water miscible bath oil immediately afterwards) • Vitamin D3 • Intensive skin hydration therapy • Limit use of soap to axillae, feet, and groin • Topical Retinoid Therapy • “Soapless” cleansers for sensitive skin • Apply lubricating emollients such as petrolatum to • Sunshine Step 3 damp skin (e.g. after bathing) • Oral antihistamines (1st generation)for sedation & relief of • Salicylic acid itching give at bedtime +/- a daytime regimen as required Step 2 • Bath additives (tar solns, oils, oatmeal, Epsom salts) • Topical hydrocortisone (0.5%) for inflammation • Colloidal oatmeal bath products Step 2 apply od-tid; ointments more effective than creams • Water miscible bath oil • Phototherapy (UVB) may use cream during day & ointment at night • Humectants: urea, lactic acid, phospholipid • Photochemotherapy (Psoralen + UVA) Step 4 Step 3 • Combination Therapies (from Step 1 & 2 treatments) • Prescription topical corticosteroids: use lowest potency • Oral antihistamines for sedation & relief of itching steroid that is effective and wean to twice weekly.
  • Immediate Hypersensitivity Reactions Caused by Drug Excipients: a Literature Review Caballero ML, Quirce S

    Immediate Hypersensitivity Reactions Caused by Drug Excipients: a Literature Review Caballero ML, Quirce S

    REVIEWS Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review Caballero ML, Quirce S Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain J Investig Allergol Clin Immunol 2020; Vol. 30(2): 86-100 doi: 10.18176/jiaci.0476 Abstract The European Medicines Agency defines excipients as the constituents of a pharmaceutical form apart from the active substance. Immediate hypersensitivity reactions (IHRs) caused by excipients contained in the formulation of medications have been described. However, there are no data on the prevalence of IHRs due to drug excipients. Clinical manifestations of allergy to excipients can range from skin disorders to life-threatening systemic reactions. The aim of this study was to review the literature on allergy to pharmaceutical excipients and to record the IHRs described with various types of medications, specifically reactions due to the excipients contained in their formulations. The cases reported were sorted alphabetically by type of medication and excipient in order to obtain a list of the excipients most frequently involved for each type of medication. Key words: Allergy. Drug immediate hypersensitivity reaction. Excipient. Pharmaceutical excipients. Resumen La Agencia Europea de Medicamentos define los excipientes como los componentes de una forma farmacéutica diferenciados del principio activo. Se han descrito reacciones de hipersensibilidad inmediata causadas por los excipientes contenidos en la formulación de medicamentos. Sin embargo, no hay datos sobre la prevalencia de dichas reacciones. Las manifestaciones clínicas de la alergia a los excipientes pueden ir desde trastornos de la piel hasta reacciones sistémicas que ponen en peligro la vida. El objetivo de este estudio fue realizar una revisión de la literatura sobre la alergia a los excipientes farmacéuticos y recopilar las reacciones inmediatas descritas con diferentes tipos de medicamento, debido solo a excipientes contenidos en sus formulaciones.